These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2190376)

  • 41. A rapid and specific assay for the du Pont aca discrete clinical analyzer, performed directly on whole blood.
    Hansen JB; Lau HP; Janes CJ; Lehane DP; Miller WK
    Transplant Proc; 1990 Jun; 22(3):1189-92. PubMed ID: 2190380
    [No Abstract]   [Full Text] [Related]  

  • 42. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 43. Annual review of transplantation.
    First MR
    Clin Transpl; 1990; ():357-73. PubMed ID: 2129410
    [No Abstract]   [Full Text] [Related]  

  • 44. Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Hakala TR; Rosenthal JT; Carpenter BJ; Taylor RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1728-9. PubMed ID: 3274417
    [No Abstract]   [Full Text] [Related]  

  • 45. Comment on cyclosporine assay techniques: an attempt for recommendations.
    Rosenthaler J; Keller HP
    Transplant Proc; 1990 Jun; 22(3):1160-5. PubMed ID: 2349679
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay, and high-performance liquid chromatography methods for the assay of serum cyclosporine.
    Schroeder TJ; Pesce AJ; Hassan FM; Wermeling JR; Warner A; Schlueter KT; First MR
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):345-7. PubMed ID: 3284078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Results of clinical and experimental use of cyclosporin A (review of foreign literature)].
    Vorob'ev AA; Konevskiĭ AG; Dvoretskaia MN
    Khirurgiia (Mosk); 1990 Jun; (6):140-3. PubMed ID: 2214567
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of cyclosporine metabolites and clinical toxicity in organ transplantation.
    Soy D; Campistol JM; Brunet M; Roca M; Carreras E; Andreu H; Codina C; Ribas J
    Transplant Proc; 1995 Aug; 27(4):2415-6. PubMed ID: 7652858
    [No Abstract]   [Full Text] [Related]  

  • 49. Cyclosporine measurement in transplantation.
    Sanghvi A; Seltman H; Diven W
    Arch Pathol Lab Med; 1985 Dec; 109(12):1072-5. PubMed ID: 3907588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Monitoring of cyclosporin A concentration in whole blood with fluorescence polarization immunoassay after bone marrow transplantation].
    Murayama T; Matsushita K; Takahashi T; Matozaki S; Nakagawa T; Isobe T
    Rinsho Ketsueki; 1992 Apr; 33(4):413-7. PubMed ID: 1602602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1193-6. PubMed ID: 2349681
    [No Abstract]   [Full Text] [Related]  

  • 52. [Heart and liver graft: therapeutic monitoring of cyclosporine by two techniques, mFPIA and EMIT].
    Gulbis B; Van der Heijden J; As HV; Thiry P
    Therapie; 1997; 52(4):327-8. PubMed ID: 9437886
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of a monoclonal antibody fluorescent polarization immunoassay with monoclonal antibody radioimmunoassay for cyclosporin determination in whole blood.
    Alvarez JS; Sacristan JA; Alsar MJ
    Ther Drug Monit; 1992 Feb; 14(1):78-80. PubMed ID: 1546394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proceedings of the Second International Congress on Cyclosporine. November 4-7, 1987, Washington, DC. II. Therapeutic use in transplantation.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1-1137. PubMed ID: 3291209
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
    J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minimal low dosage of cyclosporine therapy in renal transplantation by careful monitoring of high-performance liquid chromatography whole blood trough levels.
    Uchida K; Yamada N; Orihara A; Tominaga Y; Tanaka Y; Hayashi S; Kondo T; Morozumi K; Satake M; Taira N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):394-401. PubMed ID: 3284083
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclosporine measurement by fluorescent polarization immunoassay utilizing Abbott TDx instrument.
    Sanghvi A; Diven WF; Warty VS; Starzl T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):898-900. PubMed ID: 2650293
    [No Abstract]   [Full Text] [Related]  

  • 58. The impact of Cyclosporin A on transplantation.
    Morris PJ
    Adv Surg; 1984; 17():99-127. PubMed ID: 6367397
    [No Abstract]   [Full Text] [Related]  

  • 59. Investigation of potential interaction of ciprofloxacin with cyclosporine in bone marrow transplant recipients.
    Krüger HU; Schuler U; Proksch B; Göbel M; Ehninger G
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1048-52. PubMed ID: 2203301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for abnormal cyclosporine A metabolite concentrations.
    Offermann G; Brockmöller J; Kunzendorf U; Roots I
    Transplant Proc; 1989 Feb; 21(1 Pt 1):892-4. PubMed ID: 2650291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.